Technology

AddToAny

Google+ Facebook Twitter Twitter

Tech news: July 2023

This month's top tech news stories

Bit.Bio

Disease-relevant mutations

Bit.bio has launched its new Custom ioDisease Model Cells offering. It allows scientists to commission their disease-relevant mutation of interest in bit.bio’s human-induced pluripotent stem cell-derived cells. The disease-relevant mutation is engineered into bit.bio’s human ioWild Type cells using CRISPR/Cas9 gene editing. As disease model cells come from an identical human genetic background to ioWild Type cells, any experimental differences between the wild type and the disease model can be confidently attributed to the effects caused by the disease-specific mutations.

bit.bio


Thermo Fisher Scientific

Freelite and Hevylite assays

Thermo Fisher Scientific’s Freelite and Hevylite assays have been included in updated guidelines published by the Dutch Myeloma Working Group – part of the International Myeloma Working Group (IMWG) – for managing monoclonal gammopathies. Explicit mention of these assays adds to the weight of evidence provided by citations in more than 3800 publications and use in more than 1000 laboratories. The IMWG also used Freelite assays to establish the initial reference values for diagnosing and monitoring MGs with FLCs.

thermofisher.com


Automata

Lab automation

Automata has launched LINQ Cloud: cutting-edge laboratory automation software. LINQ Cloud connects a lab’s physical and digital environment together, enabling life science organisations to scale while reducing the manual workload for scientists. It works alongside Automata’s new LINQ automated lab bench, to create a lab automation solution specific to every lab’s workflow that enables true walkaway time. This means labs can reduce the manual workload for scientists – so they can spend more time on meaningful science. The software features an easy-to-use, intuitive interface. 

automata.tech


Image Credit | bit.bio

Related Articles

Chromosomes with telomeres - CREDIT-SPlibrary

Telomere findings may offer insights

A new study shows that an enzyme called PARP1 is involved in repair of telomeres – the lengths of DNA that protect the tips of chromosomes – and that impairing this process can lead to telomere shortening and genomic instability that can cause cancer.

Viral respiratory infection, illustration-CREDIT-science photo library C0553686

Beyond SARS-COV-2

Dr Jennifer Cane, a Postdoctoral Research Assistant, asks what sequencing respiratory viruses can tell us.

dna-CREDIT-iStock-1343372406

Microsatellite instability cancer tests

New US research compares the data of newly diagnosed cancer patients who received two different types of tests to determine their course of treatment.

mri examination-CREDIT-istock-1140748315

Novel genetic variants associated with Alzheimer’s disease

New research has identified several genetic variants that may influence Alzheimer’s disease risk, putting researchers one step closer to uncovering biological pathways to target for future treatment and prevention.

Top